CMMBChemomab Therapeutics Ltd.
- Market cap
- $7.55M
- as of 2026-10-23
- Latest close
- $1.03
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2026-06-01
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Cohen Neil Harris | Aug 28 | Sep 1 | S | 1,000 | $2.80 | Sale −$2,800 | 33,000 | No | Form 4 |
| Cohen Neil Harris | Aug 27 | Sep 1 | S | 1,304 | $2.85 | Sale −$3,716 | 34,000 | No | Form 4 |
| Cohen Neil Harris | Mar 16 | Sep 1 | A · derivative | 5,172 | $2.14 | $11,068 | 18,075 | No | Form 4 |
| Cohen Neil Harris | Mar 16, 2025 | Sep 1 | A · derivative | 3,821 | $6.16 | $23,537 | 12,903 | No | Form 4 |
| Cohen Neil Harris | Mar 18, 2024 | Sep 1 | A · derivative | 2,520 | $2.96 | $7,459 | 9,082 | No | Form 4 |
| Cohen Neil Harris | Mar 21, 2023 | Sep 1 | A · derivative | 1,714 | $6.48 | $11,107 | 6,562 | No | Form 4 |
| Cohen Neil Harris | Mar 7, 2022 | Sep 1 | A · derivative | 1,705 | $14.12 | $24,075 | 4,848 | No | Form 4 |
| Cohen Neil Harris | Apr 19, 2021 | Sep 1 | A · derivative | 2,971 | $109.04 | $323,958 | 3,143 | No | Form 4 |
| Cohen Neil Harris | Jul 16, 2020 | Sep 1 | A · derivative | 172 | $52.80 | $9,082 | 172 | No | Form 4 |
| Mor George AdiChief Executive Officer | May 29 | Jun 1 | P | 4,878 | $2.05 | Purchase +$10,000 | 134,205 | No | Form 4 |
| Mor George AdiChief Executive Officer | May 29 | Jun 1 | P | 4,926 | $2.08 | Purchase +$10,246 | 139,131 | No | Form 4 |
| Mor George AdiChief Executive Officer | May 29 | Jun 1 | J | 31,712 | not reported | not reported | 31,712 | No | Form 4 |
| Mor George AdiChief Executive Officer | May 29 | Jun 1 | J | 18,750 | not reported | not reported | 18,750 | No | Form 4 |